1278 related articles for article (PubMed ID: 32147516)
1. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
2. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
[TBL] [Abstract][Full Text] [Related]
3. Rapid review for the anti-coronavirus effect of remdesivir.
Li Z; Wang X; Cao D; Sun R; Li C; Li G
Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
[TBL] [Abstract][Full Text] [Related]
4. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
5. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Ison MG; Wolfe C; Boucher HW
JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
[No Abstract] [Full Text] [Related]
6. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua KP; Conti RM
JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
[No Abstract] [Full Text] [Related]
7. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466
[No Abstract] [Full Text] [Related]
8. [Remdesivir, the antiviral hope against SARS-CoV-2].
Reina J
Rev Esp Quimioter; 2020 Jun; 33(3):176-179. PubMed ID: 32239125
[TBL] [Abstract][Full Text] [Related]
9. [Remdesivir for patients with COVID-19].
Augustin M; Hallek M; Nitschmann S
Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
[No Abstract] [Full Text] [Related]
10. Treatments for COVID-19: where are we now?
Mendes A
Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
[No Abstract] [Full Text] [Related]
11. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
12. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
Singh AK; Singh A; Singh R; Misra A
Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
[TBL] [Abstract][Full Text] [Related]
15. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: Rescue by transcriptional inhibition.
Shilatifard A
Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
[No Abstract] [Full Text] [Related]
17. Missed Opportunities on Emergency Remdesivir Use.
Sarpatwari A; Kaltenboeck A; Kesselheim AS
JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
[No Abstract] [Full Text] [Related]
18. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
[No Abstract] [Full Text] [Related]
19. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G
Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029
[No Abstract] [Full Text] [Related]
20. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.
Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
